Gattai, Minoli, Agostinelli & Partners legal advisor to MolMed S.p.A. in the public tender offer by AGC.

Gattai, Minoli, Agostinelli & Partners was legal advisor to MolMed S.p.A., a clinical stage biotechnology company focusing on research, development, manufacturing and clinical validation of cell & gene therapies for the treatment of cancer and rare diseases, in the voluntary public tender offer by AGC Inc. for 100% of the Company’s ordinary shares, against cash payment of Euro 0.518 per ordinary share.

Gattai, Minoli, Agostinelli & Partners assisted the client with a team formed by partner Nicola Brunetti and associate Enrico Candotti.